Table 6 Essential Medicines (EMs) Availability Percentages, Prices Relative to Daily Wages, and Median Price Ratio (MRP) for Both Insured and Uninsured Costs
Insured | Uninsured | ||||
|---|---|---|---|---|---|
Availability (%) N = 30 | Mean in days (S. D) | MPR | Mean in days (S. D) | MRP | |
Paracetamol tabs | 11 (36.7%) | 1.05 (0.04) | 18.25 | 3.87 (0.36) | 68.83 |
Mebendazole suspension | 9 (30.0%) | 0.19 (0.18) | 0.56 | 0.76 (0.58) | 1.97 |
Mebendazole tabs | 10 (33.3%) | 0.33 (0.21) | 3.19 | 1.14 (0.60) | 11.16 |
acetyl salicylic acid tabs | 9 (30.0%) | 15.8 (5.88) | 89.10 | 57.20 (30.06) | 325.81 |
Amoxicillin tabs/caps | 26 (86.7%) | 3.92 (2.82) | 10.20 | 15.26 (10.79) | 39.72 |
Amoxicillin suspension | 13 (43.3%) | 0.79 (0.50) | 13.50 | 3.36 (1.80) | 57.20 |
Lidocaine injection | 2 (6.7%) | 0 (0.00) | 0 | 0 (0.00) | 0 |
Metronidazole tabs | 27 (90.0%) | 1.24 (0.18) | 8.19 | 5.23 (0.32) | 34.61 |
Artesunate injection | 5 (16.7%) | 0.54 (0.56) | 0.00 | 2.10 (2.25) | 0.011 |
Co-trimoxazole suspension | 4 (13.3%) | 0.35 (0.25) | 2.28 | 1.35 (0.90) | 8.80 |
Artemether Lumefantrine tabs | 24 (80.0%) | 0.28 (0.48) | 0.00 | 1.17 (2.02) | 0.02 |
Ferrous salt tabs | 5 (16.7%) | 2.1 (2.26) | 12.73 | 8 (8.60) | 48.50 |
Ferrous salt oral solution | 6 (20.0%) | 1.9 (3.03) | 2.77 | 7.60 (12.14) | 11.08 |
Folic acid tabs | 24 (80.0%) | 2.6 (0.17) | 14.81 | 10.40 (0.62) | 59.24 |
Benzyl benzoate lotion | 2 (6.7%) | 0 (0.00) | 0 | 0 (0.00) | 0 |
Fusidic acid ointment | 2 (6.7%) | 0.91 (0.92) | 0.85 | 3.76 (3.70) | 3.49 |
Salbutamol tabs | 6 (20.0%) | 1.4 (1.21) | 10.22 | 5.30 (4.66) | 38.69 |
Ciprofloxacin eye drops | 7 (23.3%) | 1.03 (0.90) | 1.11 | 3.92 (3.47) | 4.25 |
Ringer lactate infusion | 18 (60.0%) | 1.61 (0.12) | 125.49 | 6.16 (0.55) | 480.14 |
Total Availability (%) | 210 (36.8%) | ||||
Co-trimoxazole suspension for ped | 3 (10.0%) | 1.28 (1.20) | 0.09 | 2.92 (2.56) | 0.19 |
Isoniazid tabs | 3 (10.0%) | 3.8 (6.58) | 0.00 | 21.5 (22.74) | 0.03 |
Pediatric Availability | 6 (10%) | ||||